Boris Böll
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 1%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 54
- Oncology 51
- CAR-T cell therapy research 15
- Neutropenia and Cancer Infections 13
- Co-authors
- Matthias Kochanek (51 shared papers)Alexander Shimabukuro‐Vornhagen (38 shared papers)Michael S. von Bergwelt‐Baildon (2 shared papers)Philipp Gödel (5 shared papers)Marion S. Subklewe (3 shared papers)Hans‐Joachim Stemmler (4 shared papers)Max S. Schlaak (1 shared paper)Hans Schlößer (1 shared paper)
- Journals
- Blood (22 papers)British Journal of Haematology (7 papers)Journal of Clinical Oncology (6 papers)Annals of Hematology (6 papers)European Journal Of Haematology (5 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Boris Böll
126 papers receiving 4.0k citations
Boris Böll's Hit Papers
Peers
Comparison fields: 5 of 124
- Pathology and Forensic Medicine 1.1k
- Oncology 1.5k
- Neurology 641
- Infectious Diseases 727
- Immunology 716
Countries citing papers authored by Boris Böll
This map shows the geographic impact of Boris Böll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Böll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Böll more than expected).
Fields of papers citing papers by Boris Böll
This network shows the impact of papers produced by Boris Böll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Böll. The network helps show where Boris Böll may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Böll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cytokine release syndrome Hit paper breakdown → | 2018 | 1258 |
| 2 | 2020 | 436 | |
| 3 | 2007 | 288 | |
| 4 | 2019 | 112 | |
| 5 | 2014 | 101 | |
| 6 | 2019 | 96 | |
| 7 | 2020 | 94 | |
| 8 | 2011 | 89 | |
| 9 | 2016 | 81 | |
| 10 | 2013 | 76 | |
| 11 | 2016 | 75 | |
| 12 | 2015 | 65 | |
| 13 | 2012 | 63 | |
| 14 | 2011 | 62 | |
| 15 | 2009 | 61 | |
| 16 | 2021 | 58 | |
| 17 | 2021 | 57 | |
| 18 | 2009 | 55 | |
| 19 | 2017 | 54 | |
| 20 | 2013 | 53 |
About Boris Böll
Boris Böll is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Emergency Medical Services and Critical Care and Intensive Care Medicine, having authored 145 papers that have together received 4.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (54 papers), Chronic Lymphocytic Leukemia Research (18 papers), CAR-T cell therapy research (15 papers), Sepsis Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (15 papers), Neutropenia and Cancer Infections (13 papers), Central Venous Catheters and Hemodialysis (11 papers) and CNS Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Oncology (1.5k citations), Neurology (641 citations), Infectious Diseases (727 citations) and Immunology (716 citations). Boris Böll has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Matthias Kochanek, Alexander Shimabukuro‐Vornhagen, Michael S. von Bergwelt‐Baildon, Philipp Gödel, Marion S. Subklewe, Hans‐Joachim Stemmler, Max S. Schlaak, Hans Schlößer, Dennis Alexander Eichenauer and Peter Borchmann. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Annals of Hematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.